Form D — Gilgamesh Pharma Inc.
0002107396-26-000002 · filed 2026-02-04
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $6,090,946
- Total sold
- $6,090,946
- Minimum investment
- $27,597
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Gilgamesh Pharma Inc.
- CIK
- 2107396
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 113 UNIVERSITY PLACE, SUITE 1019
NEW YORK, NY 10003 - Phone
- 929-723-4861
Related persons
-
Jonathan Sporn · Executive OfficerNEW YORK, NY
-
Andrew Kruegel · Executive OfficerNEW YORK, NY
-
Amy Kruse · DirectorNEW YORK, NY
-
Zia Huque · DirectorNEW YORK, NY
-
Phil Skolnick · DirectorNEW YORK, NY
-
Robert Berman · DirectorNEW YORK, NY
View original on SEC EDGAR.